Gene:
DRD2
dopamine receptor D2

PharmGKB contains no dosing guidelines for this gene. To report known dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this gene. To report a drug label with PGx, click here.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

To see more Clinical Variants with lower levels of criteria, click the button at the bottom of the table.

Position ? Drug ? Relevance ? Strength of
Evidence ?
rs1799978 more likely to work 2
rs1799978 more likely to work 2
rs6277 more likely to cause weight gain 3
rs1079598 more likely to cause weight gain 3
rs1799732 less likely to work 3
rs1799978 more likely to cause hyperprolactinemia 3

Download a summary of all Clinical Annotations available.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

PharmGKB contains no genetic tests for this gene. To report genetic tests, click here.

The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.

The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page.

Links in the "Drugs" column lead to PharmGKB Drug Pages.

Variant?
(build 132)
Alternate Names ? Drugs ? Alleles ? Function ? Amino Acid?
Translation
No VIP available No Clinical Annotations available VA
rs1076560 A/C Intronic
No VIP available CA VA
rs1079598 G/A Intronic
No VIP available No Clinical Annotations available VA
rs1110976 T/G Intronic
No VIP available No Clinical Annotations available VA
rs1125394 T/C Intronic
rs1799732 DRD2: -141C Ins/Del, g.16908668_16908669insG, g.4749_4750insC -/G 5' Flanking
No VIP available CA VA
rs1799978 DRD2: -241A>G, DRD2:A-241G, g.16908767T>C, g.4651A>G T/C 5' Flanking
VIP No Clinical Annotations available No Variant Annotations available
rs1800497 32806C>T, DRD2 Taq1A, DRD2:32806C>T, DRD2:Taq1A, DRD2:Taq1A A1, DRD2:TaqIA allele, Taq1A, c.2137G>A, g.112776038G>A, g.16833244G>A, g.16833244G>C, g.16833244G>T, g.17316G>A, p.Glu713Lys C > T Missense Glu713Lys
VIP No Clinical Annotations available No Variant Annotations available
rs1801028 DRD2:1097C>G, DRD2:Ser311Cys, c.845C>G, c.932C>G, g.16845900G>C, g.67518C>G, p.Ser282Cys, p.Ser311Cys G > C Missense Ser311Cys
No VIP available No Clinical Annotations available VA
rs2283265 C/A Intronic
No VIP available No Clinical Annotations available VA
rs4436578 C/T Intronic
No VIP available No Clinical Annotations available VA
rs6275 A > G Synonymous His284His
No VIP available No Clinical Annotations available VA
rs6276 DRD2: A1385G, c.*52G>A, g.16843813C>T, g.69605G>A T/C 3' UTR
rs6277 C957T, DRD2: C957T, DRD2:1035C>T, DRD2:1122C>T, DRD2:957C>T, c.870C>T, c.957C>T, g.16845875G>A, g.67543C>T G > A Synonymous Pro319Pro
Alleles, Functions, and Amino Acid Translations are all sourced from dbSNP build 132

Overview

Alternate Names:  D(2) dopamine receptor; dopamine D2 receptor; dopamine receptor D2 isoform; seven transmembrane helix receptor
Alternate Symbols:  D2DR; D2R
PharmGKB Accession Id: PA27478

Details

Cytogenetic Location: chr11 : q23.2 - q23.2
GP mRNA Boundary: chr11 : 113280317 - 113346001
GP Gene Boundary: chr11 : 113277317 - 113356001
Strand: minus
Product Name: dopamine receptor D2, dopamine receptor D2 isoform long, dopamine receptor D2 isoform short, seven transmembrane helix receptor
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

PharmGKB Curated Pathways

Pathways created internally by PharmGKB based primarily on literature evidence.

  1. Nicotine Pathway (Dopaminergic Neuron), Pharmacodynamics
    Representation of genes involved in nicotine effects in dopaminergic neurons.

External Pathways

Links to non-PharmGKB pathways.

  1. regulation of ck1/cdk5 by type 1 glutamate receptors - (BioCarta via Pathway Interaction Database)

No related genes are available.

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other genes is available.

Curated Information ?

Drug Class Relationship Evidence
antidepressants
  •   
  •   
Publications
antipsychotics
  • PD
  • PK
Publications, Variants
artemisinin and derivatives
  • PD
  • PK
Publications
Drugs used in nicotine dependence
  • PD
  •   
Publications
Lithium
  • PD
  •   
Publications
Other antipsychotics
  • PD
  • PK
Publications
Psychostimulants, Agents Used For Adhd And Nootropics
  • PD
  •   
Publications
selective beta-2-adrenoreceptor agonists
  • PD
  •   
Publications
Selective serotonin reuptake inhibitors
  • PD
  •   
Publications

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other drugs is available.

Curated Information ?

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other diseases is available.

LinkOuts

Entrez Gene:
1813
OMIM:
126450
159900
UCSC Genome Browser:
NM_000795
RefSeq RNA:
NM_000795
NM_016574
RefSeq Protein:
NP_000786
NP_057658
RefSeq DNA:
AC_000054
AC_000143
NC_000011
NG_008841
NT_033899
NW_001838042
NW_925173
UniProtKB:
DRD2_HUMAN (P14416)
Ensembl:
ENSG00000149295
GenAtlas:
DRD2
GeneCard:
GC11M113314 (1813)
SOURCE:
DRD2
MutDB:
DRD2
PromoLign:
ortho_4615
ALFRED:
LO000168P
HuGE:
DRD2
Comparative Toxicogenomics Database:
1813
ModBase:
P14416
HumanCyc Gene:
HS07602
IUPHAR Receptor:
D2 (215)
HGNC:
3023

Common Searches

Non-Curated Publications

A list of non-curated publications that mention this gene is available.

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.